Innovation in pharmaceuticals is coming fast and shows no sign of slowing. Cell and gene therapies are potentially lifesaving, but precision medicine, at least for now, comes with a hefty price tag. Zolgensma, which treats spinal muscular atrophy, costs upwards of $2 million and is currently one of the most expensive drugs in the US. Join industry experts to learn about what?s coming next in pharmacy and what clinical and financial strategies employer plan sponsors are using to plan for the future.
